Repurposing the drug verteporfin as anti-neoplastic therapy for glioblastoma
Neuro Oncol
.
2022 May 4;24(5):708-710.
doi: 10.1093/neuonc/noac019.
Author
Renee D Read
1
Affiliation
1
Department of Pharmacology and Chemical Biology, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
PMID:
35100422
PMCID:
PMC9071275
DOI:
10.1093/neuonc/noac019
No abstract available
Publication types
Editorial
Comment
MeSH terms
Brain Neoplasms* / drug therapy
Cell Line, Tumor
Drug Repositioning
Glioblastoma* / drug therapy
Humans
Verteporfin / pharmacology
Verteporfin / therapeutic use
Substances
Verteporfin
Grants and funding
R01 NS100967/NS/NINDS NIH HHS/United States